RxDoctor Payments Data

Nadav Sahar, MD

Gastroenterology · Cincinnati, OHNPI 1922596279

Payments from drug & device makers

$2,185in general payments, 2019–2025

Across 27 payments — averaging $80.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ovesco Endoscopy USA, Inc.$786
  • Boston Scientific$523
  • ERBE USA Inc$200
  • Olympus America Inc.$166
  • Takeda Pharmaceuticals U.S.A., Inc.$143
  • Steris Corporation$137
  • plus $231 from 3 others

What the payments were for

  • Travel & lodging$1,01446%
  • Food & beverage$1,17154%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ovesco Endoscopy USA, Inc.1$786
Boston Scientific3$523
ERBE USA Inc1$200
Olympus America Inc.10$166
Takeda Pharmaceuticals U.S.A., Inc.6$143
Steris Corporation1$137
Conmed Corporation1$134
QOL Medical, LLC2$54
AbbVie2$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,185 in reported general payments places this provider in the 45th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$87,357
Medicare patients
298
Services billed
494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg276$5,494
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates43$2,707
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl40$688
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl26$367
Omeprazole29$329
Ondansetron Hcl144$207
Lansoprazole11$139

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →